7Baggers
 Press Release Distribution & PR Platform  ACCESS Newswire Mon, 28 Apr 2025 05:24:34 GMT
 press release distribution & pr platform  ACCESS Newswire Fri, 25 Apr 2025 07:00:33 GMT
 Federal Circuit Affirms ImmunoGen Patent Obviousness  NatLawReview.com Wed, 12 Mar 2025 07:00:00 GMT
 immunogen, inc. to host earnings call  ACCESS Newswire Mon, 10 Mar 2025 04:10:00 GMT
 immunogen, inc. to host earnings call  ACCESS Newswire Thu, 06 Mar 2025 13:15:42 GMT
 immunogenic cancer vaccine targets key mutations in kidney cancer  Oncology Nurse Advisor Tue, 11 Feb 2025 08:00:00 GMT
 Vaccine for HIV kickstarts key immune cell shift  futurity.org Tue, 21 Jan 2025 08:00:00 GMT
 hiv vaccine candidate activates crucial immune function  Medical Xpress Wed, 15 Jan 2025 08:00:00 GMT
 hiv vaccine candidate activates crucial immune function  Duke Health Tue, 14 Jan 2025 08:00:00 GMT
 shareholder alert: ademi llp investigates whether immunogen, inc  GuruFocus.com Sat, 21 Dec 2024 01:48:28 GMT
 abbvie completes immunogen acquisition  Contract Pharma Mon, 02 Dec 2024 08:00:00 GMT
 gilead snaps up hiv jab from barcelona-based research partner  FirstWord Pharma Mon, 25 Nov 2024 08:00:00 GMT
 gilead buys experimental hiv vaccines from a small barcelona biotech  Endpoints News Mon, 25 Nov 2024 08:00:00 GMT
 Anti-(idio)typical: a new immunogen to vaccinate against RSV  Fred Hutchinson Cancer Center Fri, 22 Nov 2024 08:00:00 GMT
 AbbVie bags EU nod for key drug from ImmunoGen takeover  pharmaphorum Mon, 18 Nov 2024 08:00:00 GMT
 m&a bright spot: abbvie's elahere gains eu approval in ovarian cancer  FirstWord Pharma Mon, 18 Nov 2024 08:00:00 GMT
 abbvie to acquire immunogen in $10.1 billion deal  MSN Tue, 05 Nov 2024 11:29:56 GMT
 seaport therapeutics names lauren white as chief financial officer  Business Wire Tue, 05 Nov 2024 08:00:00 GMT
 targeting lysosomal thiols for immunogenic cancer cell death  Wiley Online Library Mon, 04 Nov 2024 08:00:00 GMT
 Immunogenic amines on lipid nanoparticles  Nature Wed, 23 Oct 2024 07:00:00 GMT
 ligachem biosciences appoints dr. soto from immunogen as cmo  BusinessKorea Wed, 23 Oct 2024 07:00:00 GMT
 neoantigen study reshapes cancer immunotherapy approach  Drug Discovery & Development Tue, 01 Oct 2024 07:00:00 GMT
 ema committee endorses abbvie's elahere in ovarian cancer  Yahoo Finance Mon, 23 Sep 2024 07:00:00 GMT
 vaccination campaign with new immunogen is successful in guantanamo  radioguantanamo.icrt.cu Tue, 17 Sep 2024 22:05:55 GMT
 immunogen's $6,220 ovarian cancer drug to be shipped within days  Yahoo Canada Sports Sat, 27 Jul 2024 08:51:13 GMT
 barclays downgrades immunogen (imgn)  MSN Fri, 26 Jul 2024 16:35:27 GMT

ImmunoGen, Inc
(NASDAQ:IMGN) 

IMGN stock logo

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ov...

Founded: 1981
Full Time Employees: 75
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends